Biotechnology has reentered the Select Industries portfolio as improving fundamentals and a sharp sentiment rebound lifted the group into Attractive territory. While policy risks remain, the backdrop of stronger earnings revisions and reasonable valuations supports a renewed allocation to the sector.
Oct
08
2025
Leuthold Portfolios Update - September 2025
Login
For full access, please enter your credentials.
Not a Subscriber?
If you are interested in subscribing to The Leuthold Group, contact us online or give us a call at 612-332-1567.
Contact UsAbout The Author
